CYCCP - Cyclacel Pharmaceuticals Inc
Previous close
5.85
0 0%
Share volume: 0
Last Updated: Thu 26 Dec 2024 02:30:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$5.85
0.00
0.00%
Fundamental analysis
4%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
10%
Performance
5 Days
0 0%
1 Month
-4.15%
3 Months
-4.57%
6 Months
-13.73%
1 Year
-61.92%
2 Year
-35.62%
Key data
Stock price
$5.85
DAY RANGE
$5.85 - $8.00
52 WEEK RANGE
$5.63 - $22.05
52 WEEK CHANGE
-$61.69
DIVIDEND
$0.15
EX-DIVIDEND DATE
01/19/2024
NEXT EARNINGS DATE
N/A
Company detail
CEO: Spiro Rombotis
Region: US
Website: http://www.cyclacel.com/
Employees: 15
IPO year: -
Issue type:
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: http://www.cyclacel.com/
Employees: 15
IPO year: -
Issue type:
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
cyclacel limited is a pharmaceuticals company located in 46-48 e smithfield, london, united kingdom.
Recent news